Skip to content

State of the Art Technology

We apply the most recent methodologies to do our analysis

At Biosfer Teslab we are committed to constant technological innovation to provide the best service for our customers. We use the high-performance Nuclear Magnetic Resonance technology and we develop our own software for analyzing each type of biological sample. We are a multidisciplinary team with extensive research experience.

Metabolomics

Metabolomics studies the interaction between a living organism and its environment. This science analyzes a large number of metabolites, that is, small molecules derived from the metabolism – in a given individual. The result provides the metabolic footprint of the individual.

Copia de Sin título (20 × 10 cm) (10 × 5 cm) (7)
nmr technology

Nuclear Magnetic Resonance

Nuclear magnetic resonance (NMR) is one of the technologies used for metabolomics studies. It is a cutting-edge and innovative technology, which allows the absolute and simultaneous quantification of dozens of metabolites. NMR is a non-destructive (analyzes an intact sample), quantitative, automatic, robust, reproducible, andhigh-performance technique. Therefore, it allows for the reliable and accurateanalysis of the compounds found in the sample. 

Artificial Intelligence

The result obtained from the NMR is combined with Artificial Intelligence (AI)algorithms that allow us to translate the molecular information obtained from the different parameters into useful and relevant information in the care and management of metabolic well-being. 

ai

The Added Value We Offer

Our metabolomic platform is automated and allows the quick analysis of up to 200 samples per day. The results are validated in an environment of operational excellence.  The added value that we offer is data analysis. We help each researcher to interpret the data that we generate.  We are researchers specialized in Nuclear Magnetic Resonance and we get closely involved in every project.

We guarantee

Are you interested in these technologies?

ACCIÓ GRANT

BIOSFER TESLAB, SL with the support of ACTION in the frame of the Operative Program FEDER Catalonia 2014-2020 has carried out the “DEVELOPMENT And VALIDATION OF ADVANCED DIAGNOSTIC TEST Of INFLAMMATION And  INSULIN RESISTANCE FOR THE IMPROVEMENT OF  CARDIOVASCULAR RISK USING NUCLEAR MAGNETIC RESONANCE”  (RD15-1-0013).

Biosfer Teslab, along the project, has developed a system of prediction, using of advanced prediction tests, with the aim to improve the evaluation of cardiovascular risk and to identify those individuals with residual cardiovascular risk that would remain undiagnosed with classical risk factors.

In particular, the company has developed a glycoprotein test and a LMWM test - that includes, branched amino acids -, as they have been identified as inflammatory markers and involved in insulin resistance processes, respectively.

The Agency for the Competitiveness of the Company, ACTION, aiding to industrial research centers and experimental development, has granted Biosfer Teslab with an amount of 67,728.97 €.

This aid is programmed in the axis 1, "Boost research, technological development and innovation", specific objective OE 1.2.2, "Transfer and spreading of technology and cooperation between companies and universities or other research centers", line of action "Collaborative R+D projects" under the framework of the FEDER Operational Program of Catalonia 2014-2020